TABLE 1. Percentage of women aged 15–44 years with private employer-sponsored insurance who filled a prescription for a medication commonly prescribed for attention-deficit/hyperactivity disorder (ADHD), by selected demographic characteristics — United States, 2003–2015.
| Characteristic | % by year |
% Increase 2003 to 2015* | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | ||
|
Age group (yrs)†
| ||||||||||||||
| 15–19 |
2.0 |
2.6 |
3.0 |
3.4 |
3.4 |
3.9 |
4.2 |
4.4 |
4.6 |
4.8 |
4.9 |
5.1 |
5.4 |
170 |
| 20–24 |
1.0 |
1.4 |
1.8 |
2.3 |
2.5 |
3.1 |
3.5 |
4.1 |
4.5 |
4.8 |
5.0 |
5.2 |
5.5 |
450 |
| 25–29 |
0.5 |
0.6 |
0.8 |
1.0 |
1.2 |
1.5 |
1.9 |
2.2 |
2.7 |
3.0 |
3.3 |
3.5 |
4.0 |
700 |
| 30–34 |
0.5 |
0.6 |
0.8 |
1.0 |
1.0 |
1.3 |
1.5 |
1.8 |
2.1 |
2.3 |
2.6 |
2.9 |
3.3 |
560 |
| 35–39 |
0.6 |
0.7 |
0.9 |
1.1 |
1.1 |
1.3 |
1.6 |
1.8 |
2.0 |
2.2 |
2.4 |
2.6 |
3.0 |
400 |
| 40–44 |
0.6 |
0.8 |
1.0 |
1.1 |
1.1 |
1.3 |
1.5 |
1.7 |
1.9 |
2.1 |
2.3 |
2.6 |
2.9 |
383 |
|
U.S. region†,§,¶,**
| ||||||||||||||
| Northeast |
0.8 |
1.0 |
1.3 |
1.4 |
1.4 |
1.7 |
1.9 |
2.3 |
2.6 |
2.8 |
3.0 |
3.1 |
3.2 |
300 |
| North Central |
1.0 |
1.3 |
1.5 |
1.7 |
1.7 |
2.0 |
2.2 |
2.6 |
3.0 |
3.3 |
3.6 |
3.7 |
4.0 |
300 |
| South |
1.0 |
1.4 |
1.6 |
1.9 |
2.0 |
2.4 |
2.7 |
3.1 |
3.5 |
3.8 |
4.2 |
4.4 |
4.8 |
380 |
| West |
0.6 |
0.7 |
0.8 |
1.0 |
1.1 |
1.2 |
1.4 |
1.6 |
1.9 |
2.0 |
2.1 |
2.3 |
2.6 |
333 |
|
Medication class
| ||||||||||||||
| Any ADHD |
0.9 |
1.1 |
1.4 |
1.6 |
1.7 |
2.0 |
2.3 |
2.6 |
2.9 |
3.2 |
3.4 |
3.6 |
4.0 |
344 |
| Stimulant |
0.8 |
0.9 |
1.2 |
1.4 |
1.6 |
1.9 |
2.2 |
2.5 |
2.8 |
3.1 |
3.3 |
3.5 |
3.9 |
388 |
| Nonstimulant |
0.2 |
0.3 |
0.3 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0.2 |
0 |
| No. of eligible women†† | 2,508,874 | 2,502,007 | 2,464,780 | 2,347,850 | 4,123,520 | 4,644,384 | 5,443,982 | 5,843,448 | 6,662,828 | 6,822,137 | 5,889,264 | 6,063,330 | 4,580,924 | — |
Source: Truven Health MarketScan Commercial Database.
* The same woman could be included in multiple years of data; the percentage change estimation describes the overall percentage change in the percentage of reproductive-aged women who filled ADHD medication prescriptions from 2003 to 2015 by each demographic characteristic.
† Percentage with prescriptions dispensed was calculated among the total population of eligible women (i.e., women aged 15–44 years enrolled ≥11 member months per year in a plan that includes prescription drug coverage) who met the particular demographic characteristic for each age group and geographic region, respectively.
§ Among women eligible for the analytic sample, data for U.S. geographic region were missing for 0.2%–2.9%; data are not presented here.
¶ The U.S. region categories used by the Truven Health MarketScan Commercial Database align with the U.S. Census regions. The North Central region in the MarketScan Commercial Database is congruent with the Midwest Census region.
** Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
†† Women aged 15–44 years enrolled ≥11 member months per year in a plan that includes prescription drug coverage.